Cutia Therapeutics (2487.HK)

HKD 5.8

(11.75%)

Total Liabilities Summary of Cutia Therapeutics

  • Cutia Therapeutics's latest annual total liabilities in 2023 was 357.75 Million CNY , down -86.72% from previous year.
  • Cutia Therapeutics's latest quarterly total liabilities in 2024 Q2 was 319.44 Million CNY , down 0.0% from previous quarter.
  • Cutia Therapeutics reported annual total liabilities of 2.69 Billion CNY in 2022, up 17.84% from previous year.
  • Cutia Therapeutics reported annual total liabilities of 2.28 Billion CNY in 2021, down 0.0% from previous year.
  • Cutia Therapeutics reported quarterly total liabilities of 319.44 Million CNY for 2024 Q2, down 0.0% from previous quarter.
  • Cutia Therapeutics reported quarterly total liabilities of 357.75 Million CNY for 2023 FY, down -86.72% from previous quarter.

Annual Total Liabilities Chart of Cutia Therapeutics (2023 - 2021)

Historical Annual Total Liabilities of Cutia Therapeutics (2023 - 2021)

Year Total Liabilities Total Liabilities Growth
2023 357.75 Million CNY -86.72%
2022 2.69 Billion CNY 17.84%
2021 2.28 Billion CNY 0.0%

Peer Total Liabilities Comparison of Cutia Therapeutics

Name Total Liabilities Total Liabilities Difference
Uni-Bio Science Group Limited 152.81 Million HKD -134.107%
CK Life Sciences Int'l., (Holdings) Inc. 7.05 Billion HKD 94.931%